Veradermics, Incorporated MANE
124.39 USD -0.47 (-0.38%)
Regular-session close
123.00 -1.39 -1.12%
Pre-market · Nov 20, 7:49 AM ET
121.91 Day range 128.69
32.00 52-week range 156.63
- YTD
- +229.51%
- 1 year
- +229.51%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 187.33 +50.6% upside
Now 124.39
- Target (low)
- 172.00
- Target (mean)
- 187.33
- Target (high)
- 204.00
Ratings (0m) 7 7 buy · 0 hold · 0 sell
- Strong buy1
- Buy6
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 7
- 3 months ago 7
Included in Essentials and up
Sign in to see Revenue and earnings forecast
Reported revenue and earnings per share by year, then what analysts expect next.
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.61597 | -0.69 – -0.51 | -104.54 | +99.4% | 0 | 0.0% | 6 |
| Next quarter | -0.53 | -0.53 – -0.53 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Current year | -2.84 | -3.00 – -2.71 | -111.91 | +97.5% | 0 | 0.0% | 5 |
| Next year | -2.58 | -3.03 – -2.00 | -2.84 | +9.1% | 10.39M | 0.0% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 10, 2026 | Citigroup | Maintained | Buy | Buy |
| Nov 9, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Oct 22, 2026 | B. Riley Securities | Maintained | Buy | Buy |
| Oct 19, 2026 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Oct 19, 2026 | Needham | Maintained | Buy | Buy |
| Jul 16, 2026 | Citigroup | Maintained | Buy | Buy |
| Jul 15, 2026 | Needham | Maintained | Buy | Buy |
| Jul 15, 2026 | B. Riley Securities | Initiated | — | Buy |
| Jul 7, 2026 | Jefferies | Maintained | Buy | Buy |
| Jun 16, 2026 | LifeSci Capital | Initiated | — | Outperform |
| Jun 2, 2026 | Needham | Initiated | — | Buy |
| May 18, 2026 | Citigroup | Maintained | Buy | Buy |
| Apr 22, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Mar 2, 2026 | Cantor Fitzgerald | Initiated | — | Overweight |
| Mar 2, 2026 | Citigroup | Initiated | — | Buy |
| Mar 2, 2026 | Leerink Partners | Initiated | — | Outperform |
| Mar 2, 2026 | Jefferies | Initiated | — | Buy |
Included in Plus and up
Sign in to see Analyst trend
Two years of the analyst rating mix and the average price target against the price.
